FLR
(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
Created: | 2011-03-29 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 1 |
Bond Count | 32 |
Aromatic Bond Count | 13 |
Chemical Component Summary | |
---|---|
Name | (2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid |
Synonyms | Flurbirprofen, R-form |
Systematic Name (OpenEye OEToolkits) | (2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid |
Formula | C15 H13 F O2 |
Molecular Weight | 244.261 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.370 | C[CH](C(O)=O)c1ccc(c(F)c1)c2ccccc2 |
SMILES | OpenEye OEToolkits | 1.7.0 | CC(c1ccc(c(c1)F)c2ccccc2)C(=O)O |
Canonical SMILES | CACTVS | 3.370 | C[C@@H](C(O)=O)c1ccc(c(F)c1)c2ccccc2 |
Canonical SMILES | OpenEye OEToolkits | 1.7.0 | C[C@H](c1ccc(c(c1)F)c2ccccc2)C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1 |
InChIKey | InChI | 1.03 | SYTBZMRGLBWNTM-SNVBAGLBSA-N |
Drug Info: DrugBank
DrugBank ID | DB05289 |
---|---|
Name | Tarenflurbil |
Groups | investigational |
Description | Tarenflurbil is an investigational drug that was studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid plaque development in the brains of Alzheimer's disease patients. In June 2008 development of the drug for Alzheimer's disease was discontinued. Tarenflurbil has also been used in trials studying the treatment of Prostate Cancer. |
Synonyms |
|
Indication | Investigated for use/treatment in alzheimer's disease and prostate cancer. |
Categories |
|
CAS number | 51543-40-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Gamma-secretase subunit APH-1B | MTAAVFFGCAFIAFGPALALYVFTIATEPLRIIFLIAGAFFWLVSLLISS... | unknown | inhibitor |
Nicastrin | MATAGGGSGADPGSRGLLRLLSFCVLLAGLCRGNSVERKIYIPLNKTAPC... | unknown | inhibitor |
Gamma-secretase subunit APH-1A | MGAAVFFGCTFVAFGPAFALFLITVAGDPLRVIILVAGAFFWLVSLLLAS... | unknown | inhibitor |
Gamma-secretase subunit PEN-2 | MNLERVSNEEKLNLCRKYYLGGFAFLPFLWLVNIFWFFREAFLVPAYTEQ... | unknown | inhibitor |
Presenilin-1 | MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPL... | unknown | inhibitor |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL190083 |
PubChem | 92337 |
ChEMBL | CHEMBL190083 |
ChEBI | CHEBI:38666 |
CCDC/CSD | VEVKEP01, JOSPIT, VEVKEP, YACZIO, YACZIO01, VEVMAN |